
USD
+$0.00
(+0.00%
)At Close (As of Dec 9, 2025)
$32.16B
Market Cap
22.35
P/E Ratio
0.75
EPS
$24.41
52 Week High
$13.85
52 Week Low
CONSUMER DEFENSIVE
Sector
| Field | Value (USD) |
|---|---|
| Gross Profit | $9B |
| Total Revenue | $15B |
| Cost Of Revenue | $6.5B |
| Costof Goods And Services Sold | $6.5B |
| Operating Income | $1.8B |
| Selling General And Administrative | $4.4B |
| Research And Development | - |
| Operating Expenses | $7.1B |
| Investment Income Net | - |
| Net Interest Income | -$378M |
| Interest Income | $53M |
| Interest Expense | $431M |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $622M |
| Income Before Tax | $1.4B |
| Income Tax Expense | $385M |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | $1B |
| Comprehensive Income Net Of Tax | - |
| Ebit | $1.8B |
| Ebitda | $2.5B |
| Net Income | $1B |
| Field | Value (USD) |
|---|---|
| Total Assets | $26B |
| Total Current Assets | $5.5B |
| Cash And Cash Equivalents At Carrying Value | $1.1B |
| Cash And Short Term Investments | $1.1B |
| Inventory | $1.6B |
| Current Net Receivables | $2.7B |
| Total Non Current Assets | $20B |
| Property Plant Equipment | - |
| Accumulated Depreciation Amortization Ppe | - |
| Intangible Assets | $8.5B |
| Intangible Assets Excluding Goodwill | $8.5B |
| Goodwill | $8.8B |
| Investments | - |
| Long Term Investments | - |
| Short Term Investments | - |
| Other Current Assets | $205M |
| Other Non Current Assets | - |
| Total Liabilities | $16B |
| Total Current Liabilities | $5.7B |
| Current Accounts Payable | $2.3B |
| Deferred Revenue | - |
| Current Debt | - |
| Short Term Debt | $1.6B |
| Total Non Current Liabilities | $10B |
| Capital Lease Obligations | $225M |
| Long Term Debt | $6.9B |
| Current Long Term Debt | $1.6B |
| Long Term Debt Noncurrent | - |
| Short Long Term Debt Total | $8.7B |
| Other Current Liabilities | $1.7B |
| Other Non Current Liabilities | - |
| Total Shareholder Equity | $9.7B |
| Treasury Stock | - |
| Retained Earnings | -$93M |
| Common Stock | $19M |
| Common Stock Shares Outstanding | $1.9B |
| Field | Value (USD) |
|---|---|
| Gross Profit | $9B |
| Total Revenue | $15B |
| Cost Of Revenue | $6.5B |
| Costof Goods And Services Sold | $6.5B |
| Operating Income | $1.8B |
| Selling General And Administrative | $4.4B |
| Research And Development | - |
| Operating Expenses | $7.1B |
| Investment Income Net | - |
| Net Interest Income | -$378M |
| Interest Income | $53M |
| Interest Expense | $431M |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $622M |
| Income Before Tax | $1.4B |
| Income Tax Expense | $385M |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | $1B |
| Comprehensive Income Net Of Tax | - |
| Ebit | $1.8B |
| Ebitda | $2.5B |
| Net Income | $1B |
Sector: CONSUMER DEFENSIVE
Industry: HOUSEHOLD & PERSONAL PRODUCTS
Kenvue Inc. is a leading entity in the consumer health sector, delivering a diverse range of over-the-counter and personal care products that promote well-being. With a robust portfolio of trusted brands, the company emphasizes innovation and sustainability to drive growth in an increasingly health-conscious market. Leveraging its extensive global presence and insightful consumer data, Kenvue is poised to seize emerging health trends, presenting a compelling investment opportunity for institutional investors seeking diversification within the healthcare landscape.